Clinical trial
Clinical Translation of Senolytic Therapy With Fisetin to Improve Vascular Function in Older Adults
NCT06133634 is registered in ClinicalTrials.gov with University of Colorado, Boulder as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Translation of Senolytic Therapy With Fisetin to Improve Vascular Function in Older Adults
- Lead sponsor
- University of Colorado, Boulder
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- September 25, 2023
- Completion date
- March 31, 2027
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aging, arterial stiffness, endothelial dysfunction